Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of Testosterone Undecanoate to Improve Sexual Function in Postmenopausal Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* postmenopausal women with age between 40-60 years~* Women complain about her sexual problem and her score of Female Sexual Function Index ≤ 26.5~Exclusion Criteria:~* women with previous use of hormonal replacement or anti-psychiatric drugs within 3 months~* women with history of or present premalignancies/malignancies~* women present with liver disease or abnormal liver enzyme~* women with active cardiovascular, cerebrovascular or thromboembolic disorders~* women with Present psychiatric disease~* Partner have sexual dysfunction

- Gender: FEMALE
- Minimum Age: 40 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- Testosterone undecanoate (Type: EXPERIMENTAL): testosterone undecanoate 40 mg orally twice a week plus progynova 1mg oral daily
- placebo (Type: PLACEBO_COMPARATOR): placebo twice a week with progynova 1 mg oral daily

Based on this trial design, predict the completion outcome and termination type (if applicable).